Is PTCH2 p.Pro17= (c.51A>G) pathogenic?

PTCH2 p.Pro17= (c.51A>G) is classified Likely benign in PTCH2 (ClinVar, Single submitter, 1 submitter; last evaluated 2024-11-04). Very rare (popmax 0.00493%, eas); Associated with nevoid basal cell carcinoma syndrome.

What condition is associated with PTCH2 p.Pro17= (c.51A>G)?

PTCH2 p.Pro17= (c.51A>G) is associated with nevoid basal cell carcinoma syndrome (ClinVar).

How common is PTCH2 p.Pro17= (c.51A>G) in the general population?

PTCH2 p.Pro17= (c.51A>G) is very rare (popmax 0.00493%, eas) (gnomAD).

PTCH2 p.Pro17=

c.51A>G · VCV3691559

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Rare

very rare (popmax 0.00493%, eas)

Conditions

nevoid basal cell carcinoma syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -1.9	GERP -1.7
Overall
CADD	6.083	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00493% East Asian · 2/40,566 alleles

Filtering AF 0.000817% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000306%

Overall 0.000129% 2/1,547,838 alleles · very rare exomes 1/1,395,904 · genomes 1/151,934 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: PTCH2
Protein: p.Pro17=
Coding: c.51A>G
MANE Select: NM_003738
Type: single nucleotide variant
Location: chr1:44842882 (GRCh38)
Gene constraint: LOEUF 0.895 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 79.25

Full PTCH2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nevoid basal cell carcinoma syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

PTCH2 p.Pro17fs Uncertain significance ★ same residue
PTCH2 p.Pro17Ala Uncertain significance ★ ⚠ same residue
PTCH2 c.2976+2T>C Uncertain significance ★★ same condition
PTCH2 c.526-2A>G Uncertain significance ★★ same condition
PTCH2 c.618-6C>A Uncertain significance ★★ same condition
PTCH2 p.Ala1052Thr Uncertain significance ★★ ⚠ same condition
PTCH2 p.Ala1090Val Uncertain significance ★★ ⚠ same condition
PTCH2 p.Ala203Val Uncertain significance ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ptch2-p-pro17 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown